Trials / Recruiting
RecruitingNCT05934864
Different Molecular Subtypes of Peripheral T-cell Lymphoma, a Real-world Registry Study. (TRUST)
Different Molecular Subtypes of Peripheral T-cell Lymphoma, a Real-world Registry Study. (TRUST Study)
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,000 (estimated)
- Sponsor
- Ruijin Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A multi-center, prospective, registry study to analyze the clinical characteristics and prognosis of different molecular subtypes of peripheral T-cell lymphoma.
Detailed description
Peripheral T-cell lymphoma (PTCL）is a distinct and heterogeneous histopathologic subtype of non-Hodgkin lymphoma (NHL), accounting for \~10%. Patients with PTCL still have poor treatment response and prognosis under conventional CHOP regimen. This multi-center, prospective, registry study is designed to analyze the clinical characteristics and prognosis of different molecular subtypes of PTCL. The results can guide future precision therapy for PTCL.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| GENETIC | 84-gene penal | 84-gene penal was targeted sequenced in 1000 PTCL patients to investigate their mutation profile and molecular subtypes. |
Timeline
- Start date
- 2023-07-13
- Primary completion
- 2025-06-01
- Completion
- 2026-06-01
- First posted
- 2023-07-07
- Last updated
- 2024-05-16
Locations
6 sites across 1 country: China
Source: ClinicalTrials.gov record NCT05934864. Inclusion in this directory is not an endorsement.